Skip to main content
Clinical Trials/JPRN-UMIN000024322
JPRN-UMIN000024322
Completed
Phase 2

Prospective study of safety and usefulness of transcatheter arterial chemo- embolization by miriplatin and lipiodol for thoracic malignant tumors - Transcatheter arterial chemo- embolization by miriplatin and lipiodol for thoracic malignant tumors

Kameda Medical Center0 sites30 target enrollmentOctober 11, 2016

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Kameda Medical Center
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 11, 2016
End Date
December 1, 2019
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. The patients without inclusion criteria. 2\. The patients with allergy for blood vessel contrast medium. 3\. The patients with renal failure. 4\. The patients who are judged to be unsuitable by doctors.

Outcomes

Primary Outcomes

Not specified

Similar Trials